CIK 0001823239 · Accelerated filer
MARAVAI LIFESCIENCES HOLDINGS, INC.
Sign in to watch- Ticker
- MRVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (858) 546-0004
- Business address
- 10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-17 | LUCIER GREGORY T Director | Grant or award | +24,000 | 55,123 | ||
| 2023-07-17 | GRAY SUSANNAH Director | Grant or award | +24,000 | 60,123 | ||
| 2023-07-17 | MIHAS CONSTANTINE S Director | Grant or award | +24,000 | 28,271 | ||
| 2023-07-17 | MARKER LUKE JOSEPH Director | Grant or award | +24,000 | 28,271 | ||
| 2023-07-17 | DAVERMAN BENJAMIN JAMES Director | Grant or award | +24,000 | 28,271 | ||
| 2023-04-28 | Herde Kevin Chief Financial Officer | Grant or award | +874 | $11.72 | $10K | 92,064 |
| 2023-04-28 | ORESHACK KURT General Counsel | Grant or award | +1,014 | $11.72 | $12K | 63,370 |
| 2023-04-28 | Dolan Christine See Remarks | Grant or award | +1,394 | $11.72 | $16K | 73,998 |
| 2023-04-28 | Leddy Peter Michael See Remarks | Grant or award | +1,920 | $11.72 | $23K | 137,925 |
| 2023-03-15 | ORESHACK KURT General Counsel | Grant or award | +38,386 | 62,356 | ||
| 2023-03-15 | ORESHACK KURT General Counsel | Grant or award · Employee Stock Options (Right to Buy) | +76,500 | 76,500 | ||
| 2023-03-15 | Leddy Peter Michael See Remarks | Grant or award | +72,507 | 136,005 | ||
| 2023-03-15 | Leddy Peter Michael See Remarks | Grant or award · Employee Stock Options (Right to Buy) | +143,000 | 143,000 | ||
| 2023-03-15 | Herde Kevin Chief Financial Officer | Grant or award | +72,507 | 91,190 | ||
| 2023-03-15 | Herde Kevin Chief Financial Officer | Grant or award · Employee Stock Options (Right to Buy) | +143,000 | 143,000 | ||
| 2023-03-15 | Dolan Christine See Remarks | Grant or award | +55,775 | 72,604 | ||
| 2023-03-15 | Dolan Christine See Remarks | Grant or award · Employee Stock Options (Right to Buy) | +110,000 | 110,000 | ||
| 2023-03-15 | HULL CARL Chief Executive Officer | Grant or award | +147,638 | 219,519 | ||
| 2023-03-15 | HULL CARL Chief Executive Officer | Grant or award · Employee Stock Options (Right to Buy) | +270,109 | 270,109 | ||
| 2023-02-15 | Dolan Christine See Remarks | Shares withheld for taxes | −1,956 | $15.23 | $30K | 16,829 |
Page 8 of 13 · 248 trades